Topoisomerase II as a target of antileukemia drugs: a review of controversial areas.
Zwelling
L A
LA
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
D000677:Amsacrine / Q000494:pharmacology; D000970:Antineoplastic Agents; D004247:DNA / Q000378:metabolism*; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy
D000970:Antineoplastic Agents; D000677:Amsacrine; D004247:DNA; D004250:DNA Topoisomerases, Type II